Pharmacist and physician insight of vancomycin therapeutic drug-monitoring changes. Issue 1 (16th September 2022)

• Record Type: Journal Article
• Authors: Gregory, Eric R.; Stun, Lucy; Mason, Matt J.; Wilson, Nicole M.; Hammoud, Kassem A.
• Is Part Of: Antimicrobial stewardship & healthcare epidemiology. Volume 2:Issue 1(2022)
• Publication Date: 2022-09-16
• Subjects: Anti-infective agents -- Periodicals; Nosocomial infections -- Prevention -- Periodicals; Epidemiology -- Periodicals; 614.44
• DOI: 10.1017/ash.2022.282
• Languages: English
• ISSNs: 2732-494X

Abstract

Abstract: The updated vancomycin guideline for treatment of serious methicillin-resistant Staphylococcus aureus infections prompted institutions to convert from trough to area-under-the-curve monitoring. The physician perception of the transition, coupled with that of pharmacists, was measured by pre- and postimplementation surveys. Both groups believed safety would be increased without efficacy changes.